- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 11/02 - Depsipeptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof cyclic, e.g. valinomycins
Patent holdings for IPC class C07K 11/02
Total number of patents in this class: 240
10-year publication summary
|
18
|
22
|
23
|
28
|
20
|
14
|
19
|
12
|
14
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10856 |
14 |
| NovoBiotic Pharmaceuticals, LLC | 22 |
12 |
| Onkure, Inc. | 26 |
11 |
| Chugai Seiyaku Kabushiki Kaisha | 1351 |
10 |
| Boehringer Ingelheim Animal Health USA Inc. | 417 |
9 |
| St. Jude Children's Research Hospital | 243 |
8 |
| Sirenas LLC | 10 |
5 |
| The Kitasato Institute | 151 |
4 |
| Pharma Mar, S.A. | 213 |
4 |
| The Regents of the University of Colorado, a body corporate | 2638 |
4 |
| Zoetis Services LLC | 1539 |
4 |
| Bicyclerd Limited | 144 |
4 |
| The Regents of the University of California | 19887 |
3 |
| Kaneka Corporation | 4519 |
3 |
| AureoGen Biosciences, Inc. | 3 |
3 |
| Celgene Corporation | 1400 |
3 |
| Meiji Seika Pharma Co., Ltd. | 248 |
3 |
| Merial, Inc. | 220 |
3 |
| Northeastern University | 1187 |
3 |
| University of Utah Research Foundation | 1809 |
3 |
| Other owners | 127 |